Home
/
MARAVAI LIFESCIENCES HOLDINGS, INC.
/
Financials
/
Quarterly
MARAVAI LIFESCIENCES HOLDINGS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that MARAVAI LIFESCIENCES HOLDINGS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$41.63M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$47.40M
Aug 11, 2025
Q1
2025
Mar 31, 2025
$46.85M
May 12, 2025
Q3
2025
Sep 30, 2024
$69.03M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$69.42M
Aug 11, 2025
Q1
2025
Mar 31, 2024
$64.18M
May 12, 2025
Q3
2024
Sep 30, 2023
$66.87M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$68.91M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$79.03M
May 9, 2024
Q3
2023
Sep 30, 2022
$191.26M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$242.73M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$244.29M
May 9, 2023
Q3
2022
Sep 30, 2021
$204.81M
Nov 4, 2022
Q2
2022
Jun 30, 2021
$217.78M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$148.21M
May 6, 2022
Q3
2021
Sep 30, 2020
$87.86M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$46.91M
Aug 11, 2021
Q1
2021
Mar 31, 2020
$50.98M
May 12, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($25.56M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($39.59M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($29.95M)
May 12, 2025
Q3
2025
Sep 30, 2024
($97.07M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($9.79M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($12.08M)
May 12, 2025
Q3
2024
Sep 30, 2023
($6.46M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($6.54M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($67.0K)
May 9, 2024
Q3
2023
Sep 30, 2022
$44.47M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$71.24M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$66.86M
May 9, 2023
Q3
2022
Sep 30, 2021
$53.96M
Nov 4, 2022
Q2
2022
Jun 30, 2021
$49.14M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$23.10M
May 6, 2022
Q3
2021
Sep 30, 2020
$38.95M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$1.42M
Aug 11, 2021
Q1
2021
Mar 31, 2020
$23.39M
May 12, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($41.03M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($66.28M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($49.16M)
May 12, 2025
Q3
2025
Sep 30, 2024
($165.61M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($13.44M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($18.86M)
May 12, 2025
Q3
2024
Sep 30, 2023
($15.42M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($11.61M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
$2.53M
May 9, 2024
Q3
2023
Sep 30, 2022
$116.90M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$180.70M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$167.37M
May 9, 2023
Q3
2022
Sep 30, 2021
$155.38M
Nov 4, 2022
Q2
2022
Jun 30, 2021
$153.54M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$91.19M
May 6, 2022
Q3
2021
Sep 30, 2020
$45.72M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$8.12M
Aug 11, 2021
Q1
2021
Mar 31, 2020
$34.82M
May 12, 2021